1. Home
  2. ARDX vs NIC Comparison

ARDX vs NIC Comparison

Compare ARDX & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • NIC
  • Stock Information
  • Founded
  • ARDX 2007
  • NIC 2000
  • Country
  • ARDX United States
  • NIC United States
  • Employees
  • ARDX N/A
  • NIC N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • NIC Major Banks
  • Sector
  • ARDX Health Care
  • NIC Finance
  • Exchange
  • ARDX Nasdaq
  • NIC Nasdaq
  • Market Cap
  • ARDX 1.4B
  • NIC 1.4B
  • IPO Year
  • ARDX 2014
  • NIC N/A
  • Fundamental
  • Price
  • ARDX $5.11
  • NIC $111.35
  • Analyst Decision
  • ARDX Buy
  • NIC Hold
  • Analyst Count
  • ARDX 7
  • NIC 5
  • Target Price
  • ARDX $11.75
  • NIC $101.60
  • AVG Volume (30 Days)
  • ARDX 5.8M
  • NIC 67.6K
  • Earning Date
  • ARDX 10-31-2024
  • NIC 01-14-2025
  • Dividend Yield
  • ARDX N/A
  • NIC 1.01%
  • EPS Growth
  • ARDX N/A
  • NIC 102.58
  • EPS
  • ARDX N/A
  • NIC 7.86
  • Revenue
  • ARDX $251,849,000.00
  • NIC $342,790,000.00
  • Revenue This Year
  • ARDX $167.24
  • NIC N/A
  • Revenue Next Year
  • ARDX $18.93
  • NIC $4.63
  • P/E Ratio
  • ARDX N/A
  • NIC $14.16
  • Revenue Growth
  • ARDX 87.57
  • NIC 28.93
  • 52 Week Low
  • ARDX $4.06
  • NIC $72.70
  • 52 Week High
  • ARDX $10.13
  • NIC $116.17
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 44.65
  • NIC 58.77
  • Support Level
  • ARDX $4.63
  • NIC $108.52
  • Resistance Level
  • ARDX $5.24
  • NIC $116.17
  • Average True Range (ATR)
  • ARDX 0.42
  • NIC 3.23
  • MACD
  • ARDX -0.00
  • NIC -0.31
  • Stochastic Oscillator
  • ARDX 35.59
  • NIC 65.28

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

Share on Social Networks: